Here are five updates on GI companies from the past week:
Innovate Biopharmaceuticals agreed to acquire Monster Digital, an electronic camera and data storage company.
Forest Laboratories and Allergan filed a suit against Sun Pharma for patent infringement in the District of Delaware's U.S. District Court.
Takeda Pharmaceuticals President and CEO Christophe Weber could face increased scrutiny after the retirement of Chairman Yasuchika Hasegawa.
The FDA approved Salix Pharmaceuticals' new drug application for Plenvu, a lower-volume polyethylene glycol-based bowel preparation developed for bowel cleansing.
Medial EarlySign entered into a strategic collaboration with Medicover for a pilot program aimed at identifying individuals with a high colorectal cancer risk.